<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03176108</url>
  </required_header>
  <id_info>
    <org_study_id>9729</org_study_id>
    <nct_id>NCT03176108</nct_id>
  </id_info>
  <brief_title>Evaluation of a Parent/Child Cognitive-Behaviorial Therapy Program in ADHD Children With Emotional Dysregulation Profile</brief_title>
  <acronym>DP-KID</acronym>
  <official_title>Evaluation of a Parent/Child Cognitive-Behaviorial Therapy Program in ADHD Children With Emotional Dysregulation Profile : a Study Prospective, Controlled and Randomized</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Attention Deficit Disorder (ADD) with or without Hyperactivity/Impulsivity (ADHD) is a&#xD;
      neurodevelopmental syndrome that has a lasting impact on the child's daily lifestyle and&#xD;
      leads to functional impairment. ADHD is recognized as the most common psychiatry disorder in&#xD;
      children and it's considered as a public health problem.&#xD;
&#xD;
      ADHD is frequently associated with a new diagnostic entity &quot; Disruptive Disorder with&#xD;
      Emotional dysregulation &quot;. This disorder is characterized by crisis of anger with verbal or&#xD;
      physical aggression, intensity disproportionate to the context and developmental age.&#xD;
&#xD;
      Few studies have examined the elements of emotional dysregulation in ADHD in children. Many&#xD;
      studies have shown the interest of CBT in multimodal management of ADHD symptoms and&#xD;
      associated disorders.&#xD;
&#xD;
      The main objective is to evaluate the effectiveness of a Cognitive-Behavioral Therapy&#xD;
      Parent/Child program versus a body mediation focused on emotional and behaviorial aspects in&#xD;
      ADD children aged 7-13 years with dimensional emotional dysregulation at 6 months after&#xD;
      intervention. Secondary objectives are to evaluate the impact of this program, at short-term&#xD;
      (at the end of CBT) and at 6 months after intervention, on socio-communicative capacities,&#xD;
      quality of life, children's functioning and parental stress.&#xD;
&#xD;
      It's a biomedical research, prospective, controlled, randomized, monocentric, two parallels,&#xD;
      with an evaluation of the criteria of blind judgment.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      68 patients (parents and children) will be recruited within Montpellier University Hospital.&#xD;
      They will be divided into a CBT group and a control group (body mediation).&#xD;
&#xD;
      The CBT group benefits from an intervention based on the program &quot;Better manage its anger and&#xD;
      its frustrations&quot; of 15 sessions for the children.&#xD;
&#xD;
      The control group participates in an intervention of body mediation (theatre) of 15 session&#xD;
      for the children.&#xD;
&#xD;
      The parents of CBT and Control groups participate in an CBT intervention of 8 sessions every&#xD;
      15 days.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 28, 2017</start_date>
  <completion_date type="Anticipated">February 24, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 24, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Variation between the initial assessment and the month evaluation atfer the end of the intervention on the score of the &quot; Aggressive behavior &quot; subscale at the CBCL (Child Behavior Checklist)</measure>
    <time_frame>Evaluation at inclusion, 6 months and 12 months</time_frame>
    <description>The Questionnaire is completed by parents</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>:* Variation of total score on CBCL and score on &quot; Dysregulation profile &quot; (CBCL-DP) on Child Behavior Checklist</measure>
    <time_frame>Evaluation at inclusion, 6 months and 12 months</time_frame>
    <description>The Questionnaire is completed by parents</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variation of scores on &quot; Strengths and Difficulties Questionnaire &quot;</measure>
    <time_frame>Evaluation at inclusion, 6 months and 12 months</time_frame>
    <description>Description: The Questionnaire is completed by parents and teachers</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variation of scores on &quot; Parenting Stress Index &quot;</measure>
    <time_frame>Evaluation at inclusion, 6 months and 12 months</time_frame>
    <description>The Questionnaire is completed by parents</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variation of score on &quot; Beck Depression Inventory &quot;</measure>
    <time_frame>Evaluation at inclusion, 6 months and 12 months</time_frame>
    <description>The Questionnaire is completed by parents</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variation of scores on &quot; Kidscreen-27 &quot;</measure>
    <time_frame>Evaluation at inclusion, 6 months and 12 months</time_frame>
    <description>The Questionnaire is completed by parents</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variation of score on &quot; PAR-ENT-Qol &quot;</measure>
    <time_frame>Evaluation at inclusion, 6 months and 12 months</time_frame>
    <description>The Questionnaire is completed by parents</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variation of score on &quot; Children's Global Assessment Scale &quot; (C-GAS)</measure>
    <time_frame>Evaluation at inclusion, 6 months and 12 months</time_frame>
    <description>The Questionnaire is completed by the evaluator who receive parents and their child.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">68</enrollment>
  <condition>Attention Deficit Disorder With Hyperactivity</condition>
  <condition>Attention-Deficit-Disordered Children</condition>
  <arm_group>
    <arm_group_label>CBT Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The CBT group benefits of an intervention based on the program &quot;Better manage its anger and its frustrations&quot; of 15 sessions for the children.&#xD;
Parents participate in an CBT intervention of 8 sessions every 15 days. The session allow to develop adapted behaviors, to manage the disruptive behaviors and to improve the relations parents/children.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>The control group participates in an intervention of body mediation (theatre) of 15 session for the children.&#xD;
Parents participate in an CBT intervention of 8 sessions every 15 days. The session allow to develop adapted behaviors, to manage the disruptive behaviors and to improve the relations parents/children.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive Behavorial Therapy (CBT)</intervention_name>
    <description>Cognitive Behaviorial Therapy (CBT)</description>
    <arm_group_label>CBT Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Body mediation</intervention_name>
    <description>Body mediation (theatre)</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Children and adolescents aged 7-13 years ;&#xD;
&#xD;
          -  Children with a diagnostic of ADHD (diagnostics criteria from DSM-V);&#xD;
&#xD;
          -  Score CBCL-DP â‰¥ 180 (&quot; Aggressive behavior &quot;, &quot; Anxious-depression &quot; and &quot; Attention&#xD;
             problems &quot;) ;&#xD;
&#xD;
          -  Children follow-up in Montpellier University Hospital ;&#xD;
&#xD;
          -  Parents and children benefit of social security.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Children with a developmental delay or severe language disorder ;&#xD;
&#xD;
          -  Families non-french speaking ;&#xD;
&#xD;
          -  Absence of consent signed by parents and child ;&#xD;
&#xD;
          -  Children not living with at least one parent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>13 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elodie COURTABESSIS, MD PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>May 30, 2017</study_first_submitted>
  <study_first_submitted_qc>June 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 5, 2017</study_first_posted>
  <last_update_submitted>July 7, 2021</last_update_submitted>
  <last_update_submitted_qc>July 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

